Rx Medicare

The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC. As with the four previous H1N1 influenza vaccines licensed by the FDA on Sept.

Read More…

Related Posts

• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Three Additional Alabama Deaths Linked To 2009 H1N1 Influenza
• Additional Alabama Death Linked To 2009 H1N1 Influenza
• Meridian Granted Special 510(k) Clearance To Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim To The TRU FLU(R) Test Package Insert
• Additional Alabama Deaths Linked To 2009 H1N1 Influenza
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• Cases Of The 2009 H1N1 Influenza A Virus Confirmed In Crawford And Miami Counties
• HHS Takes Additional Steps Toward Development Of Vaccine For The Novel Influenza A (H1N1)
• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• As Influenza Cases Rise In Europe, Experts Urge Uptake Of H1N1 Vaccine
• Groups At High Risk Of H1N1 Influenza A Should Avoid Travelling To 2009 HAJJ
• Get Smart About Swine Flu H1N1 Swine Flu Vaccine Influenza P
• Health Canada Approves Pandemic H1N1 Flu Vaccine For Canadians
• MANUFACTURING THE H1N1 FLU VACCINE NASAL SPRAY Influenza

Tags: 2009, additional, approves, efficacy, h1n1, influenza, vaccine, virus

This entry was posted on Tuesday, November 17th, 2009 at 11:11 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.